TickerFactsScreenerDevelopers

Protalix BioTherapeutics, Inc. (PLX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2009: $44.45M2010: -$38.46M2011: -$23.57M2012: $635.0K2013: -$30.65M2014: -$29.28M2015: -$24.28M2016: -$32.10M2017: -$9.99M2018: -$7.74M2019: -$19.36M2020: -$26.11M2021: -$10.29M2022: -$25.00M2023: -$1.32M2024: $8.67M2025: -$11.99M-$11.99M
2009Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$11.99M-238.3%
2024$8.67M+758.1%
2023-$1.32M+94.7%
2022-$25.00M-143.1%
2021-$10.29M+60.6%
2020-$26.11M-34.9%
2019-$19.36M-150.0%
2018-$7.74M+22.5%
2017-$9.99M+68.9%
2016-$32.10M-32.2%
2015-$24.28M+17.1%
2014-$29.28M+4.5%
2013-$30.65M-4927.2%
2012$635.0K+102.7%
2011-$23.57M+38.7%
2010-$38.46M-186.5%
2009$44.45M—